This year, 219,449 new cases will be diagnosed in the U.S.

70 percent of lung cancer patients aren’t diagnosed until the disease has spread.

Only 15 percent of patients are still alive five years after diagnosis.

Researchers are testing a vaccine, called Lucanix™, to see if it can prevent or delay recurrence of lung cancer in patients with advanced disease.